Literature DB >> 8051107

Brain-specific receptor-type protein-tyrosine phosphatase RPTP beta is a chondroitin sulfate proteoglycan in vivo.

K Shitara1, H Yamada, K Watanabe, M Shimonaka, Y Yamaguchi.   

Abstract

By using polyclonal antiserum, which recognizes multiple proteoglycan core proteins, we isolated a cDNA species for an unknown chondroitin sulfate proteoglycan in bovine brain. Unexpectedly, DNA sequencing revealed that the cDNA encodes an open reading frame highly homologous to the human receptor-type protein-tyrosine phosphatase, RPTP beta. To prove that RPTP beta is a proteoglycan, we raised three polyclonal antibodies against extracellular and cytoplasmic domains of human RPTP beta. These antibodies have been shown to react with a smear band ranging from 350 to 500 kDa in human brain extracts. Digestion with chondroitinase ABC eliminated this smear and gave rise to a 310/300-kDa doublet band that was not detected without digestion, indicating that almost all of the RPTP beta molecules in the brain contain chondroitin sulfate chains. In the cerebellum, immunofluorescence staining of chondroitinase-treated sections revealed pericellular localization of RPTP beta in the external and internal granular layers. These data establish that RPTP beta is expressed constitutively as a chondroitin sulfate proteoglycan in the brain, and suggest that chondroitin sulfates may be an essential component for the physiological function of RPTP beta in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051107

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

Review 3.  Receptor protein tyrosine phosphatase from stem cells to mature glial cells of the central nervous system.

Authors:  Smaragda Lamprianou; Sheila Harroch
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 4.  Extracellular matrix of the central nervous system: from neglect to challenge.

Authors:  Dieter R Zimmermann; María T Dours-Zimmermann
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

Review 5.  Demystifying the extracellular matrix and its proteolytic remodeling in the brain: structural and functional insights.

Authors:  Venkat Raghavan Krishnaswamy; Amit Benbenishty; Pablo Blinder; Irit Sagi
Journal:  Cell Mol Life Sci       Date:  2019-06-13       Impact factor: 9.261

6.  Receptor-type protein-tyrosine phosphatase ζ is a functional receptor for interleukin-34.

Authors:  Sayan Nandi; Mario Cioce; Yee-Guide Yeung; Edward Nieves; Lydia Tesfa; Haishan Lin; Amy W Hsu; Robert Halenbeck; Hui-Yong Cheng; Solen Gokhan; Mark F Mehler; E Richard Stanley
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

7.  Neurons and glia modify receptor protein-tyrosine phosphatase ζ (RPTPζ)/phosphacan with cell-specific O-mannosyl glycans in the developing brain.

Authors:  Chrissa A Dwyer; Toshihiko Katoh; Michael Tiemeyer; Russell T Matthews
Journal:  J Biol Chem       Date:  2015-03-03       Impact factor: 5.157

8.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

9.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

10.  PTPRZ1 regulates calmodulin phosphorylation and tumor progression in small-cell lung carcinoma.

Authors:  Hideki Makinoshima; Genichiro Ishii; Motohiro Kojima; Satoshi Fujii; Youichi Higuchi; Takeshi Kuwata; Atsushi Ochiai
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.